These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19389516)

  • 1. Anti-tumor necrosis factor therapy and interpreting tuberculin skin tests.
    Brown AJ; Lesher JL
    J Am Acad Dermatol; 2009 May; 60(5):e21-2. PubMed ID: 19389516
    [No Abstract]   [Full Text] [Related]  

  • 2. TB screening and anti-TNF alpha treatment.
    Provenzano G; Ferrante MC; Simon G
    Thorax; 2005 Jul; 60(7):613. PubMed ID: 15994274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tuberculosis and anti-TNFalpha therapy].
    Popović-Grle S
    Reumatizam; 2007; 54(2):54-7. PubMed ID: 18351140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis screening before biologics -- T-SPOT for all?
    Gilham L; France J; Stirling A; Bawa S
    J Rheumatol; 2011 Jan; 38(1):179. PubMed ID: 21196587
    [No Abstract]   [Full Text] [Related]  

  • 5. Usefulness of enzyme-linked immunosorbent assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1464. PubMed ID: 18609725
    [No Abstract]   [Full Text] [Related]  

  • 6. Latent infection and tuberculosis disease in rheumatoid arthritis patients.
    Acevedo-Vásquez E; Ponce de León D; Gamboa-Cárdenas R
    Rheum Dis Clin North Am; 2009 Feb; 35(1):163-81. PubMed ID: 19481003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor, tuberculosis, testing, and treatment: teeing up the questions.
    Saag KG; Winthrop K; Curtis JR
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1719-21. PubMed ID: 24591413
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases.
    Soborg B; Ruhwald M; Hetland ML; Jacobsen S; Andersen AB; Milman N; Thomsen VO; Jensen DV; Koch A; Wohlfahrt J; Ravn P
    J Rheumatol; 2009 Sep; 36(9):1876-84. PubMed ID: 19648300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].
    Diel R; Hauer B; Loddenkemper R; Manger B; Krüger K
    Pneumologie; 2009 Jun; 63(6):329-34. PubMed ID: 19517358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Mycobacterium tuberculosis prior to anti-TNF therapy--an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence.
    Pradeep JD; Clunie GP; Gaffney K; Innes NJ; Brooksby A; Bradley P; Gulati A
    Rheumatology (Oxford); 2009 Feb; 48(2):195. PubMed ID: 19033354
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-TNFalpha and agranulomatous tuberculous manifestations: more diagnostic dilemma.
    Chong VH
    Neth J Med; 2009 Mar; 67(3):107. PubMed ID: 19307683
    [No Abstract]   [Full Text] [Related]  

  • 12. Making tumor necrosis factor blockers safer: a prescriber's consumptive challenge.
    Keane J; Ní Cheallaigh C
    J Rheumatol; 2008 Jul; 35(7):1238-9. PubMed ID: 18597413
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.
    Surguladze D; Deevi D; Claros N; Corcoran E; Wang S; Plym MJ; Wu Y; Doody J; Mauro DJ; Witte L; Busam KJ; Pytowski B; Rodeck U; Tonra JR
    Cancer Res; 2009 Jul; 69(14):5643-7. PubMed ID: 19584274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculin skin test: can it be replaced?
    Yeager H
    Dis Mon; 2006; 52(11-12):446-9. PubMed ID: 17157618
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrepancy between the tuberculin skin test and the levels of serum interferon-gamma in the diagnosis of tubercular infection in contacts.
    Shalabi NM; Houssen ME
    Clin Biochem; 2009 Nov; 42(16-17):1596-601. PubMed ID: 19732759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tuberculin test.
    Ruffino-Netto A
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):235-6; author reply 236. PubMed ID: 16499270
    [No Abstract]   [Full Text] [Related]  

  • 17. Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
    Wambier CG; Foss-Freitas MC; Paschoal RS; Tomazini MV; Simão JC; Foss MC; Foss NT
    J Am Acad Dermatol; 2009 May; 60(5):883-5. PubMed ID: 19389539
    [No Abstract]   [Full Text] [Related]  

  • 18. Picture of the month. Severe skin ulceration after tuberculin skin test.
    Lu CY; Lee PI; Chang LY; Chen CM; Huang LM
    Arch Pediatr Adolesc Med; 2007 Mar; 161(3):303-4. PubMed ID: 17339512
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

  • 20. Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease.
    Peyrin-Biroulet L; Colombel JF; Sandborn WJ
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1139. PubMed ID: 19465159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.